PainReform Ltd. (PRFX) Revenue History
Annual and quarterly revenue from 2017 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
PRFX Revenue Growth
PRFX Revenue Analysis (2017–2024)
As of May 8, 2026, PainReform Ltd. (PRFX) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q2 2025) recorded $0 in revenue.
Looking at the longer-term picture, PRFX's historical revenue data shows various trends over time. The company achieved its highest annual revenue of $86,000 in 2022.
When compared to Healthcare sector peers including PCRX (+4.6% YoY), ACRS (-58.2% YoY), and NKTR (-43.9% YoY). Compare PRFX vs PCRX →
PRFX Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| PRFXCurrent | $0 | - | - | - | |
 PCRX | $726M | +4.6% | +11.1% | 4.6% | |
 ACRS | $8M | -58.2% | +3.8% | -975.9% | |
 NKTR | $55M | -43.9% | -18.4% | -236.8% | |
 XTLB | $451,000 | - | - | -481.6% | |
 BHC | $10.4B | +8.5% | +5.4% | 21.3% |
PRFX Historical Revenue Data (2017–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $0 | - | $-16,000 | - | $-14,673,000 | - |
| 2023 | $0 | -100.0% | $-15,000 | - | $-9,584,000 | - |
| 2022 | $86K | - | $71K | 82.6% | $-8,869,000 | -10312.8% |
| 2021 | $0 | - | $-7,000 | - | $-7,208,000 | - |
| 2020 | $0 | - | $0 | - | $-1,671,000 | - |
| 2019 | $0 | - | $-1,000 | - | $-689,000 | - |
| 2018 | $0 | - | $0 | - | $-500,000 | - |
| 2017 | $0 | - | $0 | - | $-880,000 | - |
See PRFX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs PRFX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare PRFX vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonPRFX — Frequently Asked Questions
Quick answers to the most common questions about buying PRFX stock.
Is PRFX's revenue growth accelerating or slowing?
PRFX TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is PRFX's long-term revenue growth rate?
PainReform Ltd.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is PRFX's revenue distributed by segment?
PRFX reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2017-2024 are available for download. Segment mix reveals concentration and diversification trends.